drugset / Trial / NCT00276965
Bipolar II Depression: Lithium, SSRI, or the Combination
Phase 3
Completed
139 enrolled
Lindner Center of HOPE
National Institute of Mental Health (NIMH) · collabStanford University · collabUniversity of California, Los Angeles · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will compare the safety and effectiveness of a mood stabilizing medication, an antidepressant medication, and a combination of both medications to treat symptoms of bipolar type II depression.
Timeline
- Start
- 2006-09
- Primary completion
- 2012-03
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lithium Carbonate | Unknown | 900 mg | — |
| Subject | Sertraline | Small molecule | 200 mg | — |